📖

TDP-43 (TAR DNA-Binding Protein 43) - Biomarker

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-biomarkers-tdp-43

Related Entities

Metadata

slug	biomarkers-tdp-43
entity_type	biomarker
kg_node_id	TDP43

Linked Artifacts (118)

mentions🔬What is the therapeutic window between insufficient and toxi75%

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes75%

mentions🧫Cognitive impact of TDP-43 pathology in AD patients70%

mentions🧫TDP-43 mutant mouse model cGAS/STING pathway analysis70%

mentions🧫TDP-43 mitochondrial invasion and DNA release via mPTP70%

mentions🧫cGAS/STING pathway validation in TDP-43 mutant mice70%

mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto70%

mentions🧫cGAS/STING pathway activation by TDP-43-released mtDNA70%

mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%

mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%

mentions🧫APOE4 association with TDP-43 pathology in AD70%

mentions🧫TDP-43 pathology prevalence and distribution in AD cases70%

mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%

mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%

mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%

mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%

mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%

mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin70%

mentions🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G70%

mentions🧫Prion Strain Diversity and Selective Vulnerability in CJD70%

mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%

mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%

mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%

mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%

related🧫TDP-43 PET Ligand Development for FTD and ALS70%

related🔬What is the therapeutic window between insufficient and toxi67%

related🔬TDP-43 undergoes liquid-liquid phase separation that becomes67%

related🧫Cognitive impact of TDP-43 pathology in AD patients63%

related🧫TDP-43 mutant mouse model cGAS/STING pathway analysis63%

related🧫TDP-43 mitochondrial invasion and DNA release via mPTP63%

related🧫cGAS/STING pathway validation in TDP-43 mutant mice63%

related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto63%

related🧫cGAS/STING pathway activation by TDP-43-released mtDNA63%

related🧫s:** - Temporal analysis showing mitochondrial defects prece63%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%

related🧫APOE4 association with TDP-43 pathology in AD63%

related🧫TDP-43 pathology prevalence and distribution in AD cases63%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%

related🧫Autophagy Enhancement Drug Screening for Neurodegeneration63%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study63%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin63%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G63%

related🧫Prion Strain Diversity and Selective Vulnerability in CJD63%

related🧫Progranulin Replacement Therapy for FTD — Vector Development63%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD63%

related🧫TDP-43 PET Ligand Development for FTD and ALS63%

related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des63%

mentions🧪Cryptic Exon Silencing Restoration60%

mentions🧪Glycine-Rich Domain Competitive Inhibition60%

mentions🧪Cross-Seeding Prevention Strategy60%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%

see_also📖Amyloid-Related Imaging Abnormalities (ARIA)60%

see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%

see_also📖c9orf72-als-ftd-phenotype-mechanism60%

see_also📖CSF1R — Colony Stimulating Factor 1 Receptor60%

see_also📖CTSD — Cathepsin D60%

see_also📖Alzheimer Indonesia60%

see_also📖Packard Center for ALS Research60%

see_also📖diseases-amyotrophic-lateral-sclerosis60%

see_also📖atg4b60%

see_also📖PABPN160%

see_also📖hypotheses-apoe-contributes-alzheimers-disease-regulat60%

related🧪Cryptic Exon Silencing Restoration54%

related🧪Glycine-Rich Domain Competitive Inhibition54%

related🧪Cross-Seeding Prevention Strategy54%

related🔬What are the mechanisms underlying tdp-43 phase separation t54%

mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr50%

mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model50%

mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen50%

mentions🧪Axonal RNA Transport Reconstitution50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%

mentions🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬APOE4 differs from APOE3 by C112R causing domain interaction50%

related🔬RNA binding protein dysregulation across ALS FTD and AD50%

related🧪Stress Granule Phase Separation Modulators50%

related🧪Phase-Separated Organelle Targeting50%

related🧪RNA Granule Nucleation Site Modulation50%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

mentions🔬What are the mechanisms underlying digital biomarkers and ai40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

related🧪Heat Shock Protein 70 Disaggregase Amplification40%

related🧪Axonal RNA Transport Reconstitution40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%

related🔬What are the mechanisms underlying apoe4 structural biology 40%

related🔬What are the mechanisms underlying synaptic pruning by micro40%

related🔬Investigate prion-like spreading of tau pathology through co40%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas40%